Add BrightSurf on Google Email

More than 80% of American adults with type 2 diabetes meet treatment criteria for GLP-1 RAs or SGLT2is but most are not getting them

A study found that over 80% of American adults with type 2 diabetes meet the criteria to use GLP-1 RAs or SGLT2is, but only a small percentage are using them. The medications have a substantially higher cost than current first-line treatments, making it difficult for patients to access them.

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·TypeData/statistical analysis·DateFeb 27, 2023

Report: Science rejected, lives lost – how society can do better

A report by Queensland University of Technology highlights the struggle of international experts who warned about COVID-19 airborne transmission in early 2020. The group's warnings were initially rejected by the World Health Organisation, leading to delays in implementing control measures that could have saved lives.

SourceQueensland University of Technology·JournalClinical Infectious Diseases·TypeCommentary/editorial·DateFeb 27, 2023

Discovery suggests new way to prevent common causes of vision loss

UVA scientists have discovered a new contributor to abnormal blood vessel growth in the eye, which could lead to new treatments for macular degeneration and other vision loss conditions. The discovery identifies a key protein that determines VEGF levels, blocking it has reduced VEGF levels significantly without unwanted side effects.

SourceUniversity of Virginia Health System·JournalSignal Transduction and Targeted Therapy·DateFeb 24, 2023

The price of cancer

The study estimates the global economic cost of cancers to fall around $25.2 trillion in international dollars by 2050, accounting for 0.55% of global GDP. Lung cancer is identified as the type with the highest economic burden, followed by colon and rectum cancer, breast cancer, liver cancer, and leukemia.

SourceInternational Institute for Applied Systems Analysis·JournalJournal of the American Medical Association·DateFeb 24, 2023

Yeast used in production of cachaça can prevent asthma, study shows

A Brazilian study found that a strain of brewer's yeast can act as a preventive against asthma in male mice. Daily administration of the probiotic at a dose of 10 billion CFU/mL significantly reduced bronchial hypersensitivity and inflammation. However, airway and lung inflammation was not significantly reduced by lower doses.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalProbiotics and Antimicrobial Proteins·DateFeb 22, 2023

Celebrity tweets likely shaped US negative public opinion of COVID-19 pandemic

An analysis of 13 million tweets suggests that celebrity tweets, particularly from politicians and news anchors, played a significant role in shaping public opinion on the COVID-19 pandemic in the US. The findings highlight the importance of monitoring social media activity to combat misinformation and promote health-protective behaviors.

SourceBMJ Group·JournalBMJ Health & Care Informatics·TypeData/statistical analysis·DateFeb 21, 2023

Using sewage to forecast COVID-19 infections

A new mathematical model uses wastewater samples to predict COVID-19 cases five days in advance, detecting SARS-CoV-2 RNA with high sensitivity. The approach could help authorities tailor infection control policies when clinical surveillance is lacking.

SourceHokkaido University·JournalEnvironment International·TypeData/statistical analysis·DateFeb 20, 2023

Travellers as sentinels: what are the most common vector-borne diseases among European travellers arriving from Africa?

Researchers analyzed data on European travellers arriving from Africa between 2015 and 2019, finding malaria as the most common arthropod-borne disease. The study highlights the importance of using travellers' health data to complement local surveillance systems in Africa.

SourceEuropean Centre for Disease Prevention and Control (ECDC)·JournalEurosurveillance·TypeData/statistical analysis·DateFeb 16, 2023

Chinese Medical Journal study highlights epilepsy trends in China between 1990 and 2019

A Chinese Medical Journal study analyzed the temporal and spatial distribution of epilepsy across China, finding significant increases in incidence and prevalence rates between 1990 and 2019. The study also showed a general decrease in age-standardized DALY rates with increasing socio-demographic index.

SourceCactus Communications·JournalChinese Medical Journal·TypeData/statistical analysis·DateFeb 15, 2023

Does risk for heart disease start before birth?

Research highlights the intergenerational impact of prepregnancy heart health on offspring, with low pre-pregnancy cardiovascular health linked to pregnancy complications and higher risk for cardiovascular disease. Improving women's heart health before pregnancy could reduce these risks and have a positive impact on future generations.

SourceAmerican Heart Association·JournalCirculation·DateFeb 13, 2023

Heart failure places a great strain on healthcare

A multinational study of over 600,000 heart failure patients found that the disease is relatively fatal, with an average annual death rate of 13%, and results in high healthcare costs. The study also identified new treatment opportunities for heart failure with preserved left ventricular function.

SourceKarolinska Institutet·JournalHeart·TypeObservational study·DateFeb 13, 2023

WVU researchers estimate cost of ‘injury deaths of despair,’ including suicide, exceeds $1 trillion annually in the U.S.

The study found that estimated national costs of self-injury mortality rose by 143% from $0.46 trillion to $1.12 trillion over a 20-year period, primarily driven by increases in opioid and alcohol-related deaths. West Virginia has the highest per capita cost at $6,534, with total suicide costs increasing 58% to $502.7 billion.

SourceWest Virginia University·JournalBMC Public Health·DateFeb 9, 2023

THE LANCET: No new COVID-19 variants have emerged during China's recent outbreak, analysis of cases in Beijing suggests

An analysis of cases in Beijing found that two existing Omicron sub-variants, BA.5.2 and BF.7, accounted for more than 90% of local infections between November 14 and December 20, 2022. The study suggests these variants are chiefly responsible for the current surge in Beijing, likely China as a whole.

SourceThe Lancet·JournalThe Lancet·TypeObservational study·DateFeb 8, 2023

Ideal cardiovascular health can help people live longer, finds Chinese Medical Journal study

A large-scale observational study from China demonstrates a strong link between ideal cardiovascular health and lower mortality rates. Individuals with higher scores on behavioral and medical factors had approximately a 50% lower risk of all-cause, CVD, and respiratory mortality compared to those with lower scores.

SourceCactus Communications·JournalChinese Medical Journal·TypeObservational study·DateFeb 6, 2023

Researchers zero in on potential new function of lymphatic system: producing blood

Scientists made a groundbreaking discovery that lymphatic vessels can produce both red and white blood cells, challenging the long-held belief that blood cells come solely from bone marrow. The study suggests that lymphatic vessels may play a role in fighting infection and could be important for treating certain blood cancers.

SourceUniversity of South Australia·JournalNature·TypeExperimental study·DateFeb 5, 2023

Tuberculosis vaccine does not protect elderly against COVID-19

A large Dutch study found that the BCG vaccine does not protect elderly people with co-morbidities against COVID-19 symptoms. The study analyzed 6,112 participants and showed no difference in disease manifestations or hospitalizations between those who received the vaccine and those who received a placebo.

SourceUniversity Medical Center Utrecht·JournalClinical Microbiology and Infection·TypeRandomized controlled/clinical trial·DateFeb 2, 2023

Mapping Mexico’s dengue fever hotspots

A Rutgers researcher has analyzed data from Mexico's Ministry of Health to identify dengue fever hotspots, highlighting areas where severe outbreaks occur. The study found that lower socioeconomic status increases risk of dengue fever and that DENV-2 is the deadliest serotype.

SourceRutgers University·JournalEcological Informatics·TypeContent analysis·DateFeb 1, 2023

Better models show how infectious diseases spread

A new model has integrated two classic approaches to improve disease spread predictions, accounting for age-specific contact patterns and location-specific data. The model outperformed previous approaches in simulation studies and case studies, providing valuable insights into disease prevention and control.

SourceKing Abdullah University of Science & Technology (KAUST)·JournalStochastic Environmental Research and Risk Assessment·DateJan 30, 2023

Identified mechanism involved in development and intensification of cancer treatment-related pain

A study found that immune checkpoint inhibitors enhance chemotherapy-induced neuropathic pain by blocking interaction between macrophages and neurons via PD1-PDL1 synergy. This discovery could lead to the development of therapeutic alternatives to prevent pain while maintaining anti-neoplastic effects.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalCancer Immunology Research·DateJan 30, 2023

New study finds depression, poor mental health linked to higher heart disease risks among young adults

A new study by Johns Hopkins Medicine researchers found that young adults with depression are more likely to develop cardiovascular disease and have poor heart health. The study analyzed data from over half a million people between the ages of 18 and 49 and found that those who self-reported feeling depressed or having poor mental heal...

SourceJohns Hopkins Medicine·JournalJournal of the American Heart Association·DateJan 30, 2023

Study shows prevalence of long COVID in a university community

A study published in Emerging Infectious Diseases suggests that long COVID affects up to 36% of university community members who tested positive for COVID-19. The research identifies potential risk factors, including vaccination status and underlying medical conditions, which can reduce the risk of developing long COVID.

SourceGeorge Washington University·JournalEmerging Infectious Diseases·TypeObservational study·DateJan 26, 2023

Small study shows promise for antimalarial monoclonal antibody to prevent malaria

Researchers at the University of Maryland School of Medicine found that monoclonal antibody CIS43LS provided high levels of protection against controlled human malaria infection. The study's findings suggest that this treatment could be a potential game changer for deploying monoclonal antibody therapies in African countries.

SourceUniversity of Maryland School of Medicine·JournalThe Lancet Infectious Diseases·TypeRandomized controlled/clinical trial·DateJan 25, 2023

UCalgary and WHO researchers find hybrid immunity is the best protection against COVID-19

Researchers from UCalgary and the World Health Organization found that people with hybrid immunity have the highest level of protection against severe illness and reinfection, offering a key finding for public policy makers. The study suggests vaccination should be prioritized even among those who have had COVID-19.

SourceUniversity of Calgary·JournalThe Lancet Infectious Diseases·TypeMeta-analysis·DateJan 20, 2023

New hope for treatment of rare metabolic disease

A controlled clinical trial has shown that the new drug leriglitazone can prevent neurodegeneration and brain inflammation in patients with X-linked adrenoleukodystrophy. The study found improvements in neurological conditions such as balance disorders, which had a positive impact on quality of life.

SourceUniversität Leipzig·JournalThe Lancet Neurology·TypeRandomized controlled/clinical trial·DateJan 20, 2023

THE LANCET: Experts call for greater cooperation between human, animal and environmental health organisations to protect against future public health crises

A new Lancet Series argues that a 'One Health' approach is needed to prevent, monitor, and respond to public health emergencies globally. The series calls for greater investment in preventive and preparedness interventions, as well as greater representation of environmental organisations.

SourceThe Lancet·JournalThe Lancet·TypeSystematic review·DateJan 19, 2023

New study showed how people interacted with chatbots during COVID-19 pandemic

A new study analyzed nearly 20,000 conversations between online users and a chatbot called SimSimi to understand user interactions during the COVID-19 pandemic. The researchers found that daily chats with the chatbot mostly led to positive emotions and reduced negative moods during lockdowns.

SourceInstitute for Basic Science·JournalJournal of Medical Internet Research·TypeData/statistical analysis·DateJan 18, 2023